SS-31 Side Effects: Safety Signals and Warnings
SS-31 safety concerns are compound-specific. The main listed side effects are Injection site reactions, Headache, and Mild gastrointestinal symptoms. The main warning signals are Still in clinical trials, not yet FDA-approved, Long-term safety profile not fully established, and Some clinical trials have shown mixed results.
Direct Answer
Evidence for SS-31 (elamipretide) is too preliminary to support a research protocol with confidence. Despite promising mitochondrial mechanistic data and early trials, Phase 3 results for Barth syndrome and heart failure have been mixed or failed to meet primary endpoints. Of the Anti-Aging & Longevity compounds, NAD+ precursors and carnosine have better-established human evidence profiles.
- Evidence grade
- Level B
- Research status
- Phase 3
- Category
- Anti-Aging & Longevity
- Best for
- Mitochondrial dysfunction research, cardioprotection, oxidative stress
Reported Side Effects
- Injection site reactions
- Headache
- Mild gastrointestinal symptoms
- Generally well-tolerated in clinical trials
Warnings
- Still in clinical trials, not yet FDA-approved
- Long-term safety profile not fully established
- Some clinical trials have shown mixed results
- Cost may be significant if approved
Known or Plausible Interactions
- Other mitochondrial-targeted agents
- Statins (may have complementary mitochondrial effects)
- Drugs metabolized by mitochondrial enzymes
Regulatory Context
Investigational drug in Phase 3 clinical trials. Not yet FDA-approved. Fast Track designation from FDA for Barth syndrome. Orphan drug designation for several rare mitochondrial conditions. Not available as a research peptide in most markets.
Evidence Snapshot
| Evidence grade | Level B |
|---|---|
| Research status | Phase 3 |
| Best supported outcomes | Mitochondrial Function (Level B), Heart Failure (Level B), Exercise Capacity (Level B), and Kidney Protection (Level C) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "SS-31 Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/ss-31-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.